Dolby Laboratories, Inc. Quarterly Revenues in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Dolby Laboratories, Inc. quarterly/annual Revenues history and growth rate from Q1 2010 to Q2 2024.
  • Dolby Laboratories, Inc. Revenues for the quarter ending June 28, 2024 was $289M, a 3.2% decline year-over-year.
  • Dolby Laboratories, Inc. annual Revenues for 2021 was $1.28B, a 10.3% increase from 2020.
  • Dolby Laboratories, Inc. annual Revenues for 2020 was $1.16B, a 6.43% decline from 2019.
  • Dolby Laboratories, Inc. annual Revenues for 2019 was $1.24B, a 17.7% increase from 2018.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $289M -$9.55M -3.2% Mar 30, 2024 Jun 28, 2024 10-Q 2024-08-07
Q1 2024 $365M -$11.4M -3.02% Dec 30, 2023 Mar 29, 2024 10-Q 2024-05-02
Q4 2023 $316M -$19.3M -5.78% Sep 30, 2023 Dec 29, 2023 10-Q 2024-02-02
Q2 2023 $298M +$8.79M +3.03% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $376M +$41.5M +12.4% Dec 31, 2022 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $335M -$16.7M -4.75% Oct 1, 2022 Dec 30, 2022 10-Q 2024-02-02
Q2 2022 $1.26B $290M +$2.79M +0.97% Apr 2, 2022 Jul 1, 2022 10-Q 2023-08-03
Q1 2022 $1.26B $334M +$14.8M +4.64% Jan 1, 2022 Apr 1, 2022 10-Q 2023-05-05
Q4 2021 $1.24B $352M -$38.2M -9.81% Sep 25, 2021 Dec 31, 2021 10-Q 2023-02-02
Q3 2021 $1.28B $285M +$13.8M +5.1% Jun 26, 2021 Sep 24, 2021 10-K 2021-11-17
Q2 2021 $1.27B $287M +$39.9M +16.2% Mar 27, 2021 Jun 25, 2021 10-Q 2022-08-09
Q1 2021 $1.23B $320M -$32.3M -9.17% Dec 26, 2020 Mar 26, 2021 10-Q 2022-05-05
Q4 2020 $1.26B $390M +$98M +33.6% Sep 26, 2020 Dec 25, 2020 10-Q 2022-02-04
Q3 2020 $1.16B $271M -$27.6M -9.25% Jun 27, 2020 Sep 25, 2020 10-K 2020-11-16
Q2 2020 $1.19B $247M -$55.3M -18.3% Mar 28, 2020 Jun 26, 2020 10-Q 2021-07-29
Q1 2020 $1.24B $352M +$13.6M +4.01% Dec 28, 2019 Mar 27, 2020 10-Q 2021-05-04
Q4 2019 $1.23B $292M -$10.5M -3.47% Sep 28, 2019 Dec 27, 2019 10-Q 2021-01-29
Q3 2019 $1.24B $299M +$33.5M +12.6% Jun 29, 2019 Sep 27, 2019 10-K 2020-11-16
Q2 2019 $1.21B $302M +$87.4M +40.7% Mar 30, 2019 Jun 28, 2019 10-K 2020-11-16
Q1 2019 $1.12B $338M +$38.5M +12.9% Dec 29, 2018 Mar 29, 2019 10-K 2020-11-16
Q4 2018 $1.08B $302M +$2.85M +0.95% Sep 29, 2018 Dec 28, 2018 10-K 2020-11-16
Q3 2018 $1.08B $265M +$23.3M +9.62% Jun 30, 2018 Sep 28, 2018 10-K 2018-11-15
Q2 2018 $1.06B $215M -$90.9M -29.7% Mar 31, 2018 Jun 29, 2018 10-Q 2019-08-02
Q1 2018 $1.15B $300M +$32.2M +12.1% Dec 30, 2017 Mar 30, 2018 10-Q 2019-05-08
Q4 2017 $1.11B $300M +$33.3M +12.5% Sep 30, 2017 Dec 29, 2017 10-Q 2019-02-01
Q3 2017 $1.08B $242M +$9.05M +3.89% Jul 1, 2017 Sep 29, 2017 10-K 2018-11-15
Q2 2017 $1.07B $306M +$28.1M +10.1% Apr 1, 2017 Jun 30, 2017 10-K 2018-11-15
Q1 2017 $1.04B $267M -$6.87M -2.5% Dec 31, 2016 Mar 31, 2017 10-K 2018-11-15
Q4 2016 $1.05B $266M +$25.5M +10.6% Oct 1, 2016 Dec 30, 2016 10-K 2018-11-15
Q3 2016 $1.03B $233M +$249K +0.11% Jul 2, 2016 Sep 30, 2016 10-K 2017-11-16
Q2 2016 $1.03B $278M +$45.9M +19.8% Apr 2, 2016 Jul 1, 2016 10-K 2017-11-16
Q1 2016 $980M $274M +$2.39M +0.88% Jan 2, 2016 Apr 1, 2016 10-K 2017-11-16
Q4 2015 $977M $241M +$6.58M +2.81% Sep 26, 2015 Jan 1, 2016 10-K 2017-11-16
Q3 2015 $971M $233M +$5.79M +2.55% Jun 27, 2015 Sep 25, 2015 10-K 2016-11-18
Q2 2015 $965M $232M +$8.35M +3.74% Mar 28, 2015 Jun 26, 2015 10-K 2016-11-18
Q1 2015 $956M $272M -$6.64M -2.38% Dec 27, 2014 Mar 27, 2015 10-K 2016-11-18
Q4 2014 $963M $234M +$2.96M +1.28% Sep 27, 2014 Dec 26, 2014 10-K 2016-11-18
Q3 2014 $960M $227M +$10.3M +4.76% Jun 28, 2014 Sep 26, 2014 10-K 2015-11-24
Q2 2014 $950M $223M +$16.3M +7.86% Mar 29, 2014 Jun 27, 2014 10-K 2015-11-24
Q1 2014 $934M $279M +$29.2M +11.7% Dec 28, 2013 Mar 28, 2014 10-K 2015-11-24
Q4 2013 $904M $231M -$5.33M -2.25% Sep 28, 2013 Dec 27, 2013 10-K 2015-11-24
Q3 2013 $910M $217M -$9.1M -4.03% Jun 29, 2013 Sep 27, 2013 10-K 2014-11-18
Q2 2013 $919M $207M -$3.25M -1.54% Mar 30, 2013 Jun 28, 2013 10-K 2014-11-18
Q1 2013 $922M $249M -$13.4M -5.11% Dec 29, 2012 Mar 29, 2013 10-K 2014-11-18
Q4 2012 $935M $237M +$2.42M +1.04% Sep 29, 2012 Dec 28, 2012 10-K 2014-11-18
Q3 2012 $933M $226M -$18M -7.39% Jun 30, 2012 Sep 28, 2012 10-K 2013-11-15
Q2 2012 $951M $210M -$8.68M -3.96% Mar 31, 2012 Jun 29, 2012 10-K 2013-11-15
Q1 2012 $960M $263M +$12.7M +5.09% Dec 31, 2011 Mar 30, 2012 10-K 2013-11-15
Q4 2011 $947M $234M -$8.53M -3.52% Oct 1, 2011 Dec 30, 2011 10-K 2013-11-15
Q3 2011 $956M $244M +$16M +7.01% Jul 2, 2011 Sep 30, 2011 10-K 2012-11-15
Q2 2011 $940M $219M -$11.3M -4.89% Apr 2, 2011 Jul 1, 2011 10-K 2012-11-15
Q1 2011 $951M $250M +$6.61M +2.71% Jan 1, 2011 Apr 1, 2011 10-K 2012-11-15
Q4 2010 $944M $243M Sep 25, 2010 Dec 31, 2010 10-K 2012-11-15
Q3 2010 $228M Jun 26, 2010 Sep 24, 2010 10-K 2011-11-23
Q2 2010 $230M Mar 27, 2010 Jun 25, 2010 10-K 2011-11-23
Q1 2010 $243M Dec 26, 2009 Mar 26, 2010 10-K 2011-11-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.